Bemarituzumab in Patients with Fgfr2B-Selected Gastric or Gastro-Oesophageal Junction Adenocarcinoma (Fight) : a Randomised, Double-Blind, Placebo-Controlled, Phase 2 Study

AuthID
 P-00X-D3K
21
Author(s)
Wainberg, ZA
·
Enzinger, PC
·
Qin, SK
·
Yamaguchi, K
·
Kim, IH
·
Saeed, A
·
Oh, SC
·
Li, J
·
Turk, HM
·
[+1]·
Hitre, E
·
Udrea, AA
·
Sanchez, RG
·
Mitra, S
·
Yang, YS
·
Lee, KW
View all authors
Document Type
Article
Year published
2022
Published
in LANCET ONCOLOGY, ISSN: 1470-2045
Volume: 23, Issue: 11, Pages: 1430-1440 (11)
Indexing
Wos®
Scopus®
Pubmed®
Google Scholar®
Publication Identifiers
Pubmed: 36244398
Scopus: 2-s2.0-85140889719
Wos: WOS:000886922400038
Source Identifiers
ISSN: 1470-2045
Export Publication Metadata
Marked List
 Add to Marked List
Info
At this moment we don't have any links to full text documens.
All authors
Name Order Name   Name Order Name   Name Order Name
1 Wainberg, ZA;   2 Enzinger, PC;   3 Kang, YK;
4 Qin, SK;   5 Yamaguchi, K;   6 Kim, IH;
7 Saeed, A;   8 Oh, SC;   9 Li, J;
10 Turk, HM;   11 Teixeira, A;   12 Borg, C;
13 Hitre, E;   14 Udrea, AA;   15 Cardellino, GG;
16 Sanchez, RG;   17 Collins, H;   18 Mitra, S;
19 Yang, YS;   20 Catenacci, DVT;   21 Lee, KW;

footer slogan

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service